Leukemic stem cells and therapy resistance in acute myeloid leukemia
A major obstacle in the treatment of acute myeloid leukemia (AML) is refractory disease or relapse after achieving remission. The latter arises from a few therapy-resistant cells within minimal residual disease (MRD). Resistant cells with long-term self-renewal capacity that drive clonal outgrowth...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Ferrata Storti Foundation
2023-02-01
|
| Series: | Haematologica |
| Acceso en liña: | https://haematologica.org/article/view/10948 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|